Jeff Yass’s Journey Medical DERM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$210K Buy
30,724
+10,723
+54% +$74.7K ﹤0.01% 11839
2026
Q2
$142K Buy
20,001
+7,280
+57% +$41.6K ﹤0.01% 12251
2026
Q1
$59.7K Buy
12,721
+472
+4% +$3.66K ﹤0.01% 12584
2025
Q4
$94.4K Buy
+12,249
New +$96K ﹤0.01% 11486
2025
Q3
– Sell
-15,388
Closed -$110K – 12651
2025
Q2
$110K Sell
15,388
-41,951
-73% -$290K ﹤0.01% 11728
2025
Q1
$338K Buy
57,339
+38,617
+206% +$190K ﹤0.01% 9792
2024
Q4
$73.2K Buy
+18,722
New +$102K ﹤0.01% 11515
2022
Q4
– Sell
-22,094
Closed -$54K – 12638
2022
Q3
$54K Buy
+22,094
New +$75.3K ﹤0.01% 12146

Other funds holding DERM

Jeff Yass's DERM Position: Q3 2026 in Review

Jeff Yass increased its Journey Medical (DERM) stake by 54% in Q3 2026, buying an estimated $74.7K and bringing the position to 30,724 shares worth $210K. The position accounts for ﹤0.01% of the portfolio, ranked #11839.

Jeff Yass first reported a position in DERM in Q3 2022 and has held it in 8 quarters since. The position peaked at $338K in Q1 2025. 72 funds tracked by Wall St. Rank hold DERM as of Q3 2026.

  • Jeff Yass held 30,724 shares of Journey Medical worth $210K as of Q3 2026.
  • Jeff Yass bought 10,723 Journey Medical shares in Q3 2026, an estimated $74.7K.
  • Journey Medical made up ﹤0.01% of Jeff Yass's portfolio in Q3 2026, its #11839 holding.
  • Jeff Yass first reported a position in Journey Medical in Q3 2022 and has held it in 8 quarters since.
  • Jeff Yass's Journey Medical position peaked at $338K in Q1 2025.
  • 72 funds tracked by Wall St. Rank held Journey Medical as of Q3 2026.

Based on Susquehanna International Group's 13F filing for Q3 2026, filed 16 Nov 2026.